Pediatric endogenous endophthalmitis: Clinical features and treatment outcomes

Ridham Nanda1,2, Taraprasad Das3, Tapas Ranjan Padhi1

  • 1Department of Ophthalmology, LV Prasad Eye Institute, Mithu Tulasi Chanrai Campus, Anant Bajaj Retina Institute, Bhubaneswar, Odisha, India.

PubMed

Insights

Endogenous endophthalmitis in children, particularly those under 5 with systemic illness, carries a poor visual prognosis. Prompt ophthalmic evaluation is crucial for any child with redness and systemic infection.

Area of Science:

  • Ophthalmology
  • Pediatric Infectious Diseases
  • Microbiology

Background:

  • Endogenous endophthalmitis is a severe intraocular infection originating from a distant systemic source.
  • Pediatric cases present unique diagnostic and therapeutic challenges.
  • Gram-negative bacilli are a frequent cause of infection in this population.

Purpose of the Study:

  • To analyze the demographics, clinical-microbiological profiles, and treatment outcomes of pediatric patients diagnosed with endogenous endophthalmitis.
  • To identify risk factors associated with poor visual prognosis in children with this condition.

Main Methods:

  • Retrospective analysis of electronic medical records from 2016 to 2023 at a tertiary eye care center in India.
  • Inclusion criteria: patients under 18 years diagnosed with endogenous endophthalmitis.
  • Data collected: demographics, clinical presentation, microbiological findings, treatment, and visual outcomes.

Main Results:

  • 48 pediatric patients (average age 5.4 years) were analyzed, representing 20.8% of pediatric endophthalmitis cases.
  • Common symptoms included redness (62.5%) and vitritis (89.58%) was the most frequent sign.
  • Gram-negative bacilli (35%) were the most common isolates; systemic infection (72.9%) was prevalent, often respiratory tract infections.
  • Worse visual prognosis was observed in children under 5 with systemic illness; Gram-positive bacilli and fungal infections were linked to unfavorable outcomes.

Conclusions:

  • Redness in a child with concurrent systemic infection necessitates immediate ophthalmic assessment.
  • Young children (under 5) with systemic illness face a poorer visual prognosis.
  • Specific microbial profiles, including Gram-positive bacilli and fungi, are associated with unfavorable outcomes in pediatric endogenous endophthalmitis.
Abstract

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
374
Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
470
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
358